Skip to content
Govbase
Govbase
Congress·In Committee·H.R. 7902

To provide that the approved application under the Federal Food, Drug, and Cosmetic Act for the drug mifepristone for the purpose of the termination of intrauterine pregnancy is deemed to have been withdrawn, to establish a Federal tort for harm to women caused by chemical abortion drugs, and for other purposes.

12 days ago·View on Congress.gov

Legislative Progress

House
Senate
President
Law

Milestones

2 milestones2 actions
Mar 12, 2026House

Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Mar 12, 2026

Introduced in House

Source Information

Document Type

Congressional Bill

Bill NumberHR 7902
Congress119th Congress
ChamberHouse of Representatives
Latest ActionReferred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Sponsor

Cosponsors

(3)
R: 3

Analysis generated by AI. Always verify with official sources.